Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment

Diabetes Care

Volumn 20, Issue 9, 1997, Pages 1353-1356

  Ilkova, Hasan ^a   Glaser, Benjamin ^b   Tunçkale, Aydin ^a   Bagriaçik, Nazif ^a   Cerasi, Erol ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DETERIORATION; DIABETES CONTROL; DIET THERAPY; DOSE RESPONSE; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN PUMP; INSULIN RELEASE; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030751382     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.9.1353     Document Type: Article

References (18)

1. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 19 (Suppl. 1):S8-S15, 1996
2. Leibowitz G, Cerasi E: Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diobetologia 39:503-514, 1996
3. Edelman SV, Henry RR: Insulin therapy for normalizing glycosylated hemoglobin in type II diabetes: application, benefits, and risks. Diabetes Rev 3:308-334, 1995
4. Asplund K, Wiholm BE, Lithner F: Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia 24:412-417, 1983
5. Cerasi E: Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible? Diabetologia 38:992-997, 1995
6. Reaven G, Bernstein R, Davis B, Olefsky J: Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med 60:80-88, 1976
7. Yki-Järvinen H: Glucose toxicity. Endocr Rev 13:415-431, 1992
8. Vuorinen-Markkola H, Koivisto VA, Yki-Järvinen H: Mechanism of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type 1 diabetic patients. Diabetes 41:571-580, 1992
9. Gordon A, Glaser B, Wald M, Del Rio G, Della Casa L, Gross J, Cerasi E: Glycosylated serum protein levels assayed with highly sensitive immunoradiometric assay accurately reflect glycemic control of diabetic patients. Diabetes Care 15:645-650, 1992
10. Leahy JL, Cooper HE, Dial DA, Weir GC: Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion: a study in normal rats using chronic in-vivo glucose infusions. J Clin Invest 77:908-915, 1986
11. Samanta A, Burden AC, Jones GR, Clarkson L: The effect of short term intensive insulin therapy in non-insulin-dependent diabetics who had failed on sulphonylurea therapy. Diabet Res 3:269-271, 1986
12. Yki-Järvinen H, Esko N, Eero H, Taskinen MR: Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. Am J Med 84:185-192, 1988
13. Glaser B, Leibovich G, Nesher R, Hartling S, Binder C, Cerasi E: Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes. Acta Endocrinol 118:365-373, 1988
14. American Diabetes Association: The pharmacological treatment of hyperglycemia in NIDDM. Diabetes Care 19 (Suppl. 1):S54-S61, 1996
15. Banerji MA, Chaiken RL, Lebovitz HE: Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment. Diabetes 44:466-470, 1995
16. Banerji MA, Chaiken RL, Lebovitz HE: Long-term normoglycemic remission in black newly diagnosed NIDDM subjects. Diabetes 45:337-341, 1996
17. Kruszynska YT, Home PD, Hanning I, Alberti KGMM: Basal and 24-h C-peptide and insulin secretion rate in normal man. Diabetologia 30:16-21, 1987
18. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993